
0:00
18:34
BridgeBio recently stopped their research and development of gene therapy for Galactosemia. This came as a shock to many of us. I talked to the CEO of BridgeBio on the phone, and in this episode I report back what he told me.
More episodes from "The Galactosemia Podcast"



Don't miss an episode of “The Galactosemia Podcast” and subscribe to it in the GetPodcast app.








